Ironwood Pharmaceuticals (NASDAQ: IRWD)
Ironwood Pharmaceuticals Return vs. S&P
1 Year | 5 Year | 5 Year Annualized | Since IPO |
---|
Ironwood Pharmaceuticals Company Info
Ironwood Pharmaceuticals, Inc. is a healthcare company, which engages in the development and commercialization of Gastrointestinal (GI) products. It operates through the Human Therapeutics segment. The company was founded on January 5, 1998 and is headquartered in Boston, MA.
News & Analysis
Down 7% in 2023, This Struggling Growth Stock Could Soon Make a Turnaround
Ironwood's plan to purchase a smaller biotech should address some issues that have shareholders concerned.
Why Ironwood Pharmaceuticals Stock Bumped Higher Today
Investors indicated approval of the company's upcoming $1 billion asset purchase.
3 No-Brainer Stocks to Buy Right Now for Less Than $25
All three healthcare stocks are showing solid long-term potential.
3 Great Stocks Under $10
These stocks hold tremendous potential despite a low nominal price.
Is Ironwood Pharmaceuticals Stock a Buy?
The stock is down year to date, but a strong fourth-quarter performance could quickly turn things around.
Ironwood Pharmaceuticals' Blowout Q2 Results: What You'll Want to Know
The drugmaker delivered its first-ever quarterly profit and trounced Wall Street top- and bottom-line estimates.
Here's Why Ironwood Pharmaceuticals Rose as Much as 12% Today
An SEC filing shows an activist investor is building a sizable position in the company.
Novartis May Beat Ironwood Pharmaceuticals To The Punch
Novartis may be on track to win FDA approval of a sickle disease drug before Ironwood.
Valuation
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.